Source:http://linkedlifedata.com/resource/pubmed/id/17688413
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2007-8-10
|
pubmed:abstractText |
Genetic factors are known to be important in the development of prostate cancer. Interleukin-18 (IL-18) is a multifunctional cytokine that induces interferon-gamma secretion and plays an important role in antitumor immunity. Variations in the DNA sequence in the IL-18 gene promoter may lead to altered IL-18 production and/or activity, and so this can modulate an individual's susceptibility to prostate cancer. To test this hypothesis, we investigated the relationship of IL-18 gene promoter -137 G/C and -607 C/A polymorphisms and their haplotypes with the risk of prostate cancer. We analyzed two single nucleotide polymorphisms of IL-18 gene promoter -137 G/C and -607 C/A in 265 patients with prostate cancer and 280 age- and sex-matched controls, using sequence-specific primers-polymerase chain reaction strategy. There were significant differences in the genotype and allele distribution of -137 G/C polymorphism of the IL-18 gene among cases and controls. The -137 GC and CC genotypes were associated with a significantly increased risk of prostate cancer as compared with the -137 GG genotypes [odds ratio (OR) = 1.721; 95% confidence interval (CI): 1.187-2.496; p = 0.004, and OR = 2.181; 95% CI: 1.034-4.603; p = 0.037, for GC and CC, respectively]. Consistent with the results of the genotyping analyses, the -137C/-607A haplotype was associated with a significantly increased risk of prostate cancer as compared with the -137G/-607C haplotype (OR = 1.544; 95% CI, 1.137-2.096; p = 0.005). This study shows for the first time an association between IL-18 gene promoter -137 G/C polymorphism and prostate cancer in a Chinese population.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1044-5498
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
613-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17688413-Aged,
pubmed-meshheading:17688413-China,
pubmed-meshheading:17688413-Genetic Predisposition to Disease,
pubmed-meshheading:17688413-Haplotypes,
pubmed-meshheading:17688413-Humans,
pubmed-meshheading:17688413-Interleukin-18,
pubmed-meshheading:17688413-Male,
pubmed-meshheading:17688413-Polymorphism, Genetic,
pubmed-meshheading:17688413-Promoter Regions, Genetic,
pubmed-meshheading:17688413-Prostatic Neoplasms,
pubmed-meshheading:17688413-Risk Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer.
|
pubmed:affiliation |
Department of Scientific Research, Youjiang Medical College for Nationalities, Baise, Guangxi, People's Republic of China. liuyunguang07@163.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|